Sequenom, Inc. (NASDAQ:SQNM), a life sciences company committed to enabling healthier lives through the development of innovative products and services, today announced its 2015 investor and analyst day will be held on September 28 at 2:00 p.m. EDT in New York, NY. The presentation will include a discussion of the Company’s corporate vision and plans for reproductive health and oncology testing. (Original Source)
Shares of Sequenom closed yesterday at $2.20. SQNM has a 1-year high of $4.80 and a 1-year low of $2.03. The stock’s 50-day moving average is $2.91 and its 200-day moving average is $3.55.
On the ratings front, Sequenom has been the subject of a number of recent research reports. In a report issued on August 4, Wedbush analyst Zarak Khurshid maintained a Hold rating on SQNM, with a price target of $3.50, which implies an upside of 59.1% from current levels. Separately, on May 8, Oppenheimer’s Ling Wang reiterated a Buy rating on the stock .
According to TipRanks.com, which ranks over 7,500 financial analysts and bloggers to gauge the performance of their past recommendations, Zarak Khurshid and Ling Wang have a total average return of 0.9% and -5.8% respectively. Khurshid has a success rate of 58.0% and is ranked #2044 out of 3731 analysts, while Wang has a success rate of 35.7% and is ranked #3396.
Sequenom Inc is a molecular diagnostic testing and genetics analysis company which provides molecular diagnostic testing services.